Hyperoxia for Interstitial Lung Disease
Recruiting0 awards6 criteria
Vancouver, British Columbia
This trial aims to investigate why patients with interstitial lung disease (ILD) experience symptoms like breathlessness and exercise intolerance. The study will look at differences in the leg muscles of ILD patients, assess
Proton Beam Therapy
Precision Radiotherapy for Non-Small Cell Lung Cancer
Recruiting1 award8 criteria
Edmonton, Alberta
This trial will test a new cancer treatment in patients with Non-Small Cell Lung Cancer and Interstitial Lung Disease. Outcomes will be measured based on how well the treatment works and how safe it is.
Popular Filters
Trials for Idiopathic Pulmonary Fibrosis Patients
Procedure
Cold Saline Irrigation for Lung Disease
Recruiting1 award1 criteria
Cincinnati, Ohio
This trial aims to reduce bleeding during lung biopsies by irrigating the biopsy site with cold saline before the procedure. This may help prevent blood contamination on the pathology slides, leading to quicker and more
Procedure
Cryobiopsy vs Forceps Biopsy for Lung Disease
Recruiting1 award2 criteria
Baltimore, Maryland
This trial compares a new method to a standard one for lung biopsies. It targets patients needing lung tissue samples, aiming to improve sample quality and reduce complications. The new method works by freezing and removing tissue, providing larger and higher-quality samples with a good safety and cost-benefit profile.
Vitamin Supplement
Vitamin D for Sickle Cell Anemia
Recruiting0 awardsPhase 2
New York, New York
This trial tests if vitamin D3 can lower lung issues in kids with sickle cell disease. It compares different dosing schedules to see which works better. The goal is to find a simple, low-cost way to help these children stay healthier. Vitamin D has been studied for its potential to reduce respiratory complications in children with sickle cell disease due to its ability to fight infections and support the immune system.
Trials for Interstitial Lung Disease Patients
Procedure
Cold Saline Irrigation for Lung Disease
Recruiting1 award1 criteria
Cincinnati, Ohio
This trial aims to reduce bleeding during lung biopsies by irrigating the biopsy site with cold saline before the procedure. This may help prevent blood contamination on the pathology slides, leading to quicker and more
Procedure
Cryobiopsy vs Forceps Biopsy for Lung Disease
Recruiting1 award2 criteria
Baltimore, Maryland
This trial compares a new method to a standard one for lung biopsies. It targets patients needing lung tissue samples, aiming to improve sample quality and reduce complications. The new method works by freezing and removing tissue, providing larger and higher-quality samples with a good safety and cost-benefit profile.
Vitamin Supplement
Vitamin D for Sickle Cell Anemia
Recruiting0 awardsPhase 2
New York, New York
This trial tests if vitamin D3 can lower lung issues in kids with sickle cell disease. It compares different dosing schedules to see which works better. The goal is to find a simple, low-cost way to help these children stay healthier. Vitamin D has been studied for its potential to reduce respiratory complications in children with sickle cell disease due to its ability to fight infections and support the immune system.
Phase 3 Trials
Prostacyclin Receptor Agonist
Ralinepag for Pulmonary Arterial Hypertension
Recruiting1 awardPhase 3
Birmingham, Alabama
This trial is testing ralinepag, a medication being developed for the treatment of pulmonary arterial hypertension (PAH). It aims to see if adding ralinepag to their usual treatments can improve their condition. The medication works by relaxing and opening up the blood vessels in the lungs, which can lower the pressure and improve blood flow.
Anti-microtubule agent
Sigvotatug Vedotin vs Docetaxel for Lung Cancer
Recruiting2 awardsPhase 3
Anchorage, Alaska
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Antibiotic
Epetraborole for Mycobacterium Avium Complex Lung Disease
Recruiting0 awardsPhase 2 & 3
DeLand, Florida
This trial is testing a new drug called epetraborole, given with standard treatments, in adults with hard-to-treat MAC lung disease. The goal is to see if epetraborole can help clear the lung infection when other treatments have failed.
BI 1015550 for Interstitial Lung Disease
Recruiting1 awardPhase 3
Winston-Salem, North Carolina
This trial tests if BI 1015550 can help adults with certain progressive lung diseases. Participants take the medicine as tablets, and their lung function is checked over time to see if it improves. The study aims to find out if this new treatment can slow down the worsening of their lung condition.
Tyrosine Kinase Inhibitor
Nintedanib for Interstitial Lung Disease
Recruiting2 awardsPhase 3
Los Angeles, California
This trial tests the medicine nintedanib in children and teens with lung disease that causes scarring. The goal is to see if long-term use of nintedanib is safe and effective for them. Participants take the medicine and visit the study site for health check-ups. Nintedanib has been shown to slow disease progression and is well tolerated in patients.
Trials With No Placebo
Procedure
Cold Saline Irrigation for Lung Disease
Recruiting1 award1 criteria
Cincinnati, Ohio
This trial aims to reduce bleeding during lung biopsies by irrigating the biopsy site with cold saline before the procedure. This may help prevent blood contamination on the pathology slides, leading to quicker and more
Procedure
Cryobiopsy vs Forceps Biopsy for Lung Disease
Recruiting1 award2 criteria
Baltimore, Maryland
This trial compares a new method to a standard one for lung biopsies. It targets patients needing lung tissue samples, aiming to improve sample quality and reduce complications. The new method works by freezing and removing tissue, providing larger and higher-quality samples with a good safety and cost-benefit profile.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.